摩罗丹辅助常规西药治疗慢性萎缩性胃炎疗效观察及对EGF、EGFR 水平的影响
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R573.3+2

基金项目:


Curative Observation of Moluo Pills Combined with Routine Western Medicine for Chronic Atrophic Gastritis and Its Effect on EGF and EGFR
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察摩罗丹辅助常规西药治疗慢性萎缩性胃炎(CAG) 的临床疗效及其对表皮生长因 子(EGF)、表皮生长因子受体(EGFR) 水平的影响。方法:将80 例慢性萎缩性胃炎患者按随机数字表法分 为治疗组与对照组各40 例。对照组给予常规西药治疗,治疗组在对照组的基础上联合摩罗丹辅助治疗。2 组 均以1 个月为1 个疗程,连续治疗3 个疗程后评估临床疗效、中医证候评分、血清EGF 水平、胃黏膜EGFR 阳性率及药物不良反应发生率。结果:治疗组总有效率为92.50%,高于对照组70.00%,2 组比较,差异有统 计学意义(P<0.05)。治疗前,2 组胃脘胀满、胃脘疼痛、胸胁胀痛、纳差、口干口苦等中医证候评分比较, 差异无统计学意义(P>0.05);治疗后,2 组上述各项证候评分均较治疗前降低(P<0.05),且治疗组各项评 分均低于对照组(P<0.05)。治疗前,2 组血清EGF 水平比较,差异无统计学意义(P>0.05);治疗后,2 组 EGF 水平较治疗前降低(P<0.05),且治疗组EGF 水平低于对照组(P<0.05)。治疗前,2 组胃黏膜EGFR 阳 性率比较,差异无统计学意义(P>0.05);治疗后,2 组EGFR 阳性率较治疗前降低(P<0.05),且治疗组 EGFR 阳性率低于对照组(P<0.05)。治疗组不良反应发生率为7.50%,对照组为10.00%,2 组比较,差异无 统计学意义(P>0.05)。结论:摩罗丹辅助常规西药治疗CAG 疗效显著,有利于减轻患者临床症状,降低血 清EGF 及胃黏膜EGFR 表达水平,且用药安全性良好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Moluo Pills combined with routine western medicine for chronic atrophic gastritis (CAG) and its effects on epidermal growth factors (EGF) and epidermal growth factor receptors (EGFR). Methods:A total of 80 cases of CAG patients were divided into the control group and the treatment group according to the random number table method, with 40 cases in each group. The control group was treated with routine western medicine, and the treatment group was additionally treated with Moluo Pills based on the treatment of the control group. Both groups were treated for three courses,with one month being one course. After treatment,clinical effects,traditional Chinese medicine syndrome scores,levels of EGF in serum,the positive rates of EGFR in gastric mucosa,and the incidence of adverse reactions were evaluated. Results:The total clinical effective rate was 92.50% in the treatment group, better than that of 70.00% in the control group, the difference being significant (P< 0.05). Before treatment, there was no significant difference being found in the comparison of scores of distention and fullness in the gastric cavity,pain in the gastric cavity,distending pain in the chest and ribside, poor appetite,and dryness and bitter taste in the mouth between the two groups (P>0.05);after treatment, the above syndrome scores in the two groups were decreased when compared with those before treatment (P<0.05),and each score in the treatment group was lower than that in the control group (P<0.05). Before treatment,there was no significant difference being found in the comparison of serum EGF levels between the two groups (P>0.05); after treatment, EGF levels in the two groups were decreased when compared with those before treatment (P<0.05), and the level in the treatment group was lower than that in the control group (P<0.05). Before treatment,there was no significant difference being found in the comparison of the positive rates of EGFR in gastric mucosa between the two groups (P> 0.05); after treatment, the positive rates of EGFR in gastric mucosa in the two groups were decreased when compared with those before treatment (P<0.05),and the positive rate of EGFR in gastric mucosa in the treatment group was lower than that in the control group (P<0.05). The total incidence of adverse reactions was 7.50% in the treatment group and 10.00% in the control group,there being no significance in the difference (P>0.05). Conclusion:Moluo Pills combined with routine western medicine has significant curative effects in the treatment of CAG,and can effectively relieve clinical symptoms,reduce the levels of serum EGF and the expression of EGFR in gastric mucosa with good medication safty.

    参考文献
    相似文献
    引证文献
引用本文

徐芳,朱雅碧,王立明,尚惺杰.摩罗丹辅助常规西药治疗慢性萎缩性胃炎疗效观察及对EGF、EGFR 水平的影响[J].新中医,2023,55(6):54-58

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-03-28
  • 出版日期:
文章二维码